• Ocean Man
    Looking for the next $PBYI? As I posted last week, dips under $4 on $ADMP are to be bought. Last year's produced a triple in 2 weeks.
    7/23/14
    Reply (56)
    • Ocean Man: People ask "what's the date of the next catalyst?". To that I say, did $EGRX go up when its drug got approved this morning? No.
      7/23/14
    • Ocean Man: The money was made buying it 2 months ahead of the catalyst, when it dipped. Those people enjoyed a 55% gain.
      7/23/14
    • Ocean Man: Including the ones who followed me on it: http://seekingalpha.com/s/stuyt
      7/23/14
    • NLTInvestor: why didn't it pop?
      7/23/14
    • cking6178: I've been watching this for while now...was targeting less than $3.50, but initiated the other day @ $3.63...
      7/23/14
    • Rob Chanock: The old.....buy the rumor, sell the news adage I guess.
      7/23/14
    • sheldond: That was a good call currently green on ADMP.....after buying back in
      7/23/14
    • Toyman317: What about $MSTX?
      7/23/14
    • webbersworld: $ADMP.... I'll buy when it hits $3.50 again.
      7/23/14
    • det9: I hope you are right OM.. You know my position..
      7/23/14
    • Bio Bull: The only thing that kept this stock from a even larger downward spin is the greater awareness of its potential. I'm not convinced, though,
      7/24/14
    • Bio Bull: that the potential is ever going to be realized. Just not sure this one is going to happen at all but hope it does.
      7/24/14
    • profit698: Have the same concerns with Bio Bull. Remember I read somewhere before that the company failed to deliver what they planned in the past.
      7/24/14
    • profit698: concerned if they can deliver what they're promising this time.
      7/24/14
    • Nicholas Chen: any facts you'd like to share?
      7/24/14
    • profit698: It's from yahoo message board posted by "cheknin".
      7/24/14
    • profit698: "nothing has ever happened as anticipated. Case in point, the massive profits projected from sale of the prefilled epinephrine syringe."
      7/24/14
    • profit698: "A quick Google search will reveal a press release dated July of 2009(!) "
      7/24/14
    • profit698: "which trumpeted the launch of this product and projected profitability within 12 months."
      7/24/14
    • profit698: "Unfortunately, the company failed to get proper approvals, "
      7/24/14
    • profit698: "the product was quietly withdrawn (a fact buried in a filing) and has languished for the last five years. "
      7/24/14
    • profit698: Weird, where is my post?
      7/24/14
    • profit698: Oh, I see my post. check: http://yhoo.it/Q54HWg;_ylt=AopoTAJkeUFoOA3y8bi7RRDeAohG;_ylu=X3oDMTB2cGdsOWFsBHBvcwM0NARzZWMDTWVkaWFNc2dCb2FyZHNYSFJVbHQ-;_ylg=X3oDMTBhYWM1a2sxBGxhbmcDZW4tVVM-;_ylv=3?&bn=bd4d6641-83c6-317a-a075-ab559947fc4d&tid=1403099723877-e92bd9f6-aff3-49f8-b3f3-69194097de72&tls=la%2Cd%2C12%2C3
      7/24/14
    • Nicholas Chen: Apparently some confusion on the approval process. Hopefully they get it right this time. There were good signs from that time of sales...
      7/24/14
    • Nicholas Chen: Walgreens signed up, with Tier 1 insurance coverage. Likely will happen again. http://bit.ly/1z8kKGk
      7/24/14
    • profit698: I see the management is too weak. They haven't gotten it right for 5 years!!! It is too long!
      7/24/14
    • Nicholas Chen: Take your Yahoo message board bashing elsewhere please, "cheknin".
      7/24/14
    • profit698: Please don't call a person basher when he/she presents a different opinion.
      7/24/14
    • profit698: I did see some reports in 2009. Apparently, it didn't work out for the last 5 years.
      7/24/14
    • profit698: I am interested in this stock recently but concerned about the management's capability.
      7/24/14
    • profit698: If somebody knows the full story and can explain it, please convince us. I am all ears.
      7/24/14
    • homerun: 698, management needs make a better pitch but $ADMP owns the rights for the DPI. It's a 3M device. You don't see any value?
      7/24/14
    • profit698: Homerun, what I am concerned is the management's capability, whether they can deliver their plans.
      7/24/14
    • James W. Burke: $ADMP previously sold EPI PFS as a Tier 1 thru Walgreens & others http://bit.ly/WH6dnr - it was made available with no NDA...
      7/25/14
    • James W. Burke: via some small co. exclusion if my understanding is correct. Other EPI sellers objected and FDA then said NDA was required. With other...
      7/25/14
    • James W. Burke: things on their plate (cancer drug trials, patents, Zanetti legal challenge) and new things coming in, in particular 3M's Taper DPI, they...
      7/25/14
    • James W. Burke: couldn't get EPI NDA going again until after the secondary/uplist. If you talk to CEO, he said had to choose - obtain Taper or file EPI...
      7/25/14
    • James W. Burke: they chose Taper, which took way longer than expected, but allowed them to raise $25M via secondary and soon after get EPI NDA going
      7/25/14
    • James W. Burke: Taper DPI inhaler can get them into other markets also, not just Advair. I believe the APC5000 POC will require an IND. Not sure if any...
      7/25/14
    • James W. Burke: other INDs have been filed yet for generic Advair. As we know APC5000 POC will start 2H14 and they have the cash for it on hand.
      7/25/14
    • profit698: James: Thanks for your clarification. I really appreciate. However, I am having even more concerns regarding management's capability.
      7/25/14
    • profit698: If they focused on it, got it done, and used the profits to fund other things, would there be less dilution today?
      7/25/14
    • profit698: and would they be much financially better off today?
      7/25/14
    • profit698: "they chose Taper, which took way longer than expected". It is reasonable to be longer than expected.
      7/25/14
    • profit698: But much longer than expected raises my doubt on management's capability.
      7/25/14
    • profit698: " things on their plate (cancer drug trials...". Cancer drug is much riskier.
      7/25/14
    • profit698: Stopping half way on a profitable one and starting a riskier, remote one sounds not like a prudent move at all.
      7/25/14
    • James W. Burke: Profit698, Taper addresses much larger mkt. 3M tests vs Advair mitigates risk IMO. Without Taper, no way they raise $25M and uplist...
      7/25/14
    • James W. Burke: 3M huge company - nothing moves quickly and much focus on legal I would assume. Calling mgt with your concerns is best way to resolve - GL
      7/25/14
    • profit698: James, thank you very much!
      7/25/14
    • jonanne: James, just the fact that you have to go thought all those explanatory gyrations is a tesaiment to management's strategic ineptness.
      7/25/14
    • jonanne: which they have evidenced on many many occasions (viz, the recent premature shelf). The hope is that the products are so superior as to
      7/25/14
    • James W. Burke: I was just trying to address 140 chars at a time :)
      7/25/14
    • jonanne: overcome management's strategic failings. What gets my goat (from both a financial and ethical perspective) is that a promising oncology
      7/25/14
    • jonanne: portfolio languishes.
      7/25/14
    • profit698: Agree with jonanne.
      7/25/14